Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
Open Access
- 29 January 2021
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 13 (3) , e13167
Abstract
Severe α 1 ‐antitrypsin deficiency results from the Z allele (Glu342Lys) that causes the accumulation of homopolymers of mutant α 1 ‐antitrypsin within the endoplasmic reticulum of hepatocytes in association with liver disease. We have used a DNA‐encoded chemical library to undertake a high‐throughput screen to identify small molecules that bind to, and stabilise Z α 1 ‐antitrypsin. The lead compound blocks Z α 1 ‐antitrypsin polymerisation in vitro , reduces intracellular polymerisation and increases the secretion of Z α 1 ‐antitrypsin threefold in an iPSC model of disease. Crystallographic and biophysical analyses demonstrate that GSK716 and related molecules bind to a cryptic binding pocket, negate the local effects of the Z mutation and stabilise the bound state against progression along the polymerisation pathway. Oral dosing of transgenic mice at 100 mg/kg three times a day for 20 days increased the secretion of Z α 1 ‐antitrypsin into the plasma by sevenfold. There was no observable clearance of hepatic inclusions with respect to controls over the same time period. This study provides proof of principle that “mutation ameliorating” small molecules can block the aberrant polymerisation that underlies Z α 1 ‐antitrypsin deficiency.Keywords
All Related Versions
Funding Information
- GlaxoSmithKline
- Medical Research Council (MR/N024842/1)
- UCLH Biomedical Research Centre
- Biotechnology and Biological Sciences Research Council (BB/T002603/1)
This publication has 45 references indexed in Scilit:
- Reactive centre loop mutants of α-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathwayBioscience Reports, 2013
- Structural Dynamics Associated with Intermediate Formation in an Archetypal Conformational DiseaseStructure, 2012
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- Defining the mechanism of polymerization in the serpinopathiesProceedings of the National Academy of Sciences, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Kinetic Instability of the Serpin Z α1-Antitrypsin Promotes AggregationJournal of Molecular Biology, 2010
- Preventing serpin aggregation: The molecular mechanism of citrate action upon antitrypsin unfoldingProtein Science, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Conformational changes in serpins: I. the native and cleaved conformations of α 1 -antitrypsin 1 1Edited by J. M. ThorntonJournal of Molecular Biology, 2000
- Folding Pathway of Human α1-Antitrypsin: Characterization of an Intermediate That Is Active but Prone to AggregationBiochemical and Biophysical Research Communications, 1996